- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Intracellular space.
Displaying page 1 of 1.
EudraCT Number: 2006-004396-35 | Sponsor Protocol Number: 06078SE-A | Start Date*: 2006-10-25 |
Sponsor Name:Belfast City Hospital Trust | ||
Full Title: Investigation of the anti-inflammatory effects of simvastatin in a model of acute lung injury after inhalation of lipopolysaccharide by healthy volunteers | ||
Medical condition: Acute lung injury (ALI) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-000441-58 | Sponsor Protocol Number: 08005DM-A | Start Date*: 2009-01-22 |
Sponsor Name:Belfast City Hospital | ||
Full Title: Investigation of the protective effects of keratinocyte growth factor (KGF) in a human lipopolysaccharide induced model of acute lung injury | ||
Medical condition: Acute lung injury | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-001589-13 | Sponsor Protocol Number: N/A | Start Date*: 2012-06-26 | |||||||||||
Sponsor Name:Belfast Health and Social Care Trust | |||||||||||||
Full Title: The effect of Aspirin on REducing iNflammation in human in vivo model of Acute lung injury (ARENA) | |||||||||||||
Medical condition: The intended indication for the product under development is that of acute lung injury. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003999-40 | Sponsor Protocol Number: EONHL1-20 | Start Date*: 2021-02-09 | |||||||||||
Sponsor Name:Enterome | |||||||||||||
Full Title: A global multicenter phase 1/2 trial of EO2463, a novel microbial-derived peptide therapeutic vaccine, as monotherapy, and in combination with lenalidomide and rituximab, for treatment of patients ... | |||||||||||||
Medical condition: Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma; Marginal Zone Lymphoma) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
